LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China flag China · Delayed Price · Currency is CNY
7.34
-0.17 (-2.26%)
Nov 13, 2026, 3:04 PM CST

SHE:002644 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
941.7915.53980.231,1631,042817.64
Revenue Growth
5.13%-6.60%-15.73%11.58%27.49%22.39%
Gross Profit
313.45308.81298.76358.96304.16221.07
Operating Income
84.7969.4743.5562.966.145.65
Net Income
61.8549.2160.0767.19108.6593.26
Earnings Per Share
0.120.100.120.130.210.18
EPS Growth
4.67%-18.03%-10.64%-38.16%16.54%-13.66%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Pharmaceutical Industry
912.36978.121,1611,009798.52
Food Industry
3.172.111.81.6611.94
Total
915.53980.231,1631,042817.64

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
653.52524.49397.89406.04399.85374.94
Total Debt
21.6845.4940.7952.6355.668.65
Net Cash (Debt)
631.84479357.1353.41344.26306.29
Net Cash Growth
51.63%34.13%1.04%2.66%12.39%-12.86%
Net Cash Per Share
1.240.940.700.690.670.60

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
282.95183.9538.9865.7186.6111.85
Capital Expenditures
-35.21-18.55-13.29-22.47-41.53-32.81
Free Cash Flow
247.74165.425.743.2445.08-20.95
Free Cash Flow Growth
87.16%543.70%-40.58%-4.08%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
33.29%33.73%30.48%30.86%29.18%27.04%
Operating Margin
9.00%7.59%4.44%5.41%6.34%5.58%
Pretax Margin
8.77%7.10%7.05%7.02%12.54%13.55%
Profit Margin
6.57%5.38%6.13%5.78%10.42%11.41%
FCF Margin
26.31%18.07%2.62%3.72%4.32%-2.56%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1200.0200.0120.0300.0500.010
Dividend Per Share Growth
0%66.67%-60.00%-40.00%400.00%-91.67%
Dividend Yield
1.64%0.23%0.15%0.31%0.54%0.10%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
60.6189.6665.6374.1043.8554.98
Forward PE
-53.8853.8853.8853.8853.88
P/FCF Ratio
15.3626.68153.42115.14105.68-
PS Ratio
4.044.824.024.284.576.27